Prosecution Insights
Last updated: October 02, 2026
Application No. 18/861,017

BALLOON CATHETER FOR DELIVERING A THERAPEUTIC AGENT TO VARIABLE LENGTH TREATMENT SITES

Non-Final OA §102§103
Filed
Oct 28, 2024
Priority
Apr 26, 2022 — nonprovisional of PCTUS2022026343
Examiner
LUCCHESI, NICHOLAS D
Art Unit
Tech Center
Assignee
Bard Peripheral Vascular Inc.
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
8m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
652 granted / 832 resolved
+18.4% vs TC avg
Moderate +9% lift
Without
With
+9.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
42 currently pending
Career history
879
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
34.6%
-5.4% vs TC avg
§102
26.7%
-13.3% vs TC avg
§112
32.0%
-8.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 832 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4,6,7,8,13,14,16-18,23,24,26-30 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Slepian 5575815. With regard to claims 1,13,23,26,27, Slepian discloses a medical apparatus for treating a lesion, comprising: a shaft 45 (see fig. 2c); a first inflatable balloon 50 supported by the shaft; a second inflatable balloon 52 supported by the shaft, a longitudinal position of the second inflatable 52 balloon being adjustable relative to the first inflatable balloon 50 (see col. 12, lines 22-23 which describes how shafts 46 and 44 that comprise shaft 45 are telecscopic) ; and a third inflatable balloon 54 supported by the shaft 45 between the first inflatable balloon 50 and the second inflatable balloon 52. With regard to claim 2,13,23 note that shaft 45 comprises an outer shaft 44 supporting the first inflatable balloon 50 and an inner shaft 46 supporting the second inflatable balloon 52. With regard to claims 3,13,26 note that inner shaft 45 further supports the third inflatable balloon 54. See fig. 2C. With regard to claims 4,14,24, note that the inner shaft 45 comprises a first port proximal 56 of the third inflatable balloon 54 and a second port 56 distal of the third inflatable balloon 54. See fig. 2C. With regard to claims 6,16,28 note that the outer shaft 44 comprises a first inflation port (inherently within the first balloon) for the first inflatable balloon 50, and the inner shaft 46 comprises a second inflation port (inherently within the second inflatable balloon) for the second inflatable balloon 52 and a third inflation port (inherently within the third inflatable balloon) for the third inflatable balloon 54. With regard to claims 7,17,29, note that a proximal end of the shaft 45 comprises an infusion port (this is inherent) for communicating with at least one opening 56 in the shaft between the first inflatable balloon 50 and the third inflatable balloon 54. With regard to claims 8,18,30 note that the third balloon 54 is elongated with a barrel section for compacting the lesion when inflated (non-compliant) with tapered end sections connected to the shaft. See fig. 2C. Also, note that the first 50 and second 52 inflatable balloons are generally spherical. With further regard to claim 30, note that balloon 54 can be called the “first” balloon supported by the inner portion 46 of the shaft, and balloon 52 can be called the “second” balloon supported by the inner portion 46 of the shaft. It is also noted that the first balloon 54 is non-compliant since it is the balloon used to compact a lesion, and “second” balloon 52 is compliant since it is used to occlude during a procedure. [AltContent: textbox (Tapered end sections)][AltContent: arrow][AltContent: textbox (barrel)] [AltContent: arrow][AltContent: arrow][AltContent: arrow][AltContent: arrow] PNG media_image1.png 161 486 media_image1.png Greyscale [AltContent: textbox (“generally spherical”)] Claims 23 and 25 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Wells et al 20210106339. With regard to claim 23, Wells et al discloses a medical apparatus for treating a lesion, comprising: a shaft 102 (see fig. 2C) including telescoping inner 114 and outer 110 portions; a first inflatable balloon 105 supported by the inner portion 114 of the shaft; and a second inflatable balloon 107 supported by the inner portion 114 of the shaft. With regard to claim 25, note that Wells et al discloses that outer portion 110 of the shaft may comprise a retainer for retaining the outer portion 110 of the shaft relative to the inner portion 114 of the shaft. See paragraph 75 which discloses how the shaft portions may be locked by a locking mechanism at one end. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 5 and 15 are rejected under 35 U.S.C. 103 as being unpatentable over Slepian 5575815 in view of Wells et al 20210106339. With regard to claims 5 and 15, Slepian does not disclose that that outer portion of the shaft comprises a retainer for retaining the outer portion of the shaft relative to the inner portion of the shaft. Wells et al discloses a balloon catheter wherein the outer portion 110 of the shaft may comprise a retainer for retaining the outer portion 110 of the shaft relative to the inner portion 114 of the shaft. See paragraph 75 which discloses how the shaft portions may be locked by a locking mechanism at one end. It would have been obvious to one skilled in the art to include a retainer for retaining the outer portion of the shaft relative to the inner portion of the shaft, with the balloon catheter of Slepian, in view of the teaching of Wells et al that a balloon catheter may include a retainer for retaining inner and outer portions relative to each other. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICHOLAS D LUCCHESI whose telephone number is (571)272-4977. The examiner can normally be reached M-F 800-430. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Eric Rosen can be reached at 571-270-7855. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICHOLAS D LUCCHESI/Primary Examiner, Art Unit 3772
Read full office action

Prosecution Timeline

Oct 28, 2024
Application Filed
Sep 23, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746186
DENTAL WORKPIECE AND METHOD FOR PRODUCING SAME
1y 10m to grant Granted Sep 29, 2026
Patent 12746185
MEDICAL MATERIAL
2y 0m to grant Granted Sep 29, 2026
Patent 12740849
ARCH EXPANDING APPLIANCE
1y 1m to grant Granted Sep 22, 2026
Patent 12734020
ORTHODONTIC APPLIANCE AND ORTHODONTIC SYSTEM
2y 3m to grant Granted Sep 15, 2026
Patent 12727966
SYSTEM, DEVICE AND METHODS FOR DENTAL DIGITAL IMPRESSIONS
4y 9m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
88%
With Interview (+9.4%)
2y 7m (~8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 832 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month